We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
+5.69%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$6.04M
Cap. Flow
+$249K
Cap. Flow %
0.21%
Top 10 Hldgs %
40.15%
Holding
84
New
2
Increased
2
Reduced
53
Closed
1

Top Buys

Rank Stock Value
1
GRX
Gabelli Healthcare & Wellness Trust
GRX
+$1.44M
2
NEM icon
Newmont
NEM
+$1.09M
3
EIX icon
Edison International
EIX
+$192K
4
ONEQ icon
Fidelity Nasdaq Composite Index ETF
ONEQ
+$928

Top Sells

Rank Stock Value
1
GG
Goldcorp Inc
GG
+$1.16M
2
PG icon
Procter & Gamble
PG
+$240K
3
AAPL icon
Apple
AAPL
+$156K
4
ESS icon
Essex Property Trust
ESS
+$67.2K
5
MRK icon
Merck
MRK
+$66.2K

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.48%
2 Healthcare 12.24%
3 Materials 11.78%
4 Technology 9.17%
5 Real Estate 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.07T
$1.59M 1.33%
14,345
-289
-2% -$34K
UL icon
27
Unilever
UL
$132B
$1.56M 1.3%
22,369
-267
-1% -$18.1K
SO icon
28
Southern Company
SO
$109B
$1.55M 1.29%
28,050
– –
ABT icon
29
Abbott
ABT
$182B
$1.48M 1.23%
17,543
-210
-1% -$16.5K
GILD icon
30
Gilead Sciences
GILD
$162B
$1.46M 1.21%
21,550
-200
-0.9% -$13.2K
GRX
31
Gabelli Healthcare & Wellness Trust
GRX
$143M
$1.45M 1.21%
+137,500
New +$1.44M
LMT icon
32
Lockheed Martin
LMT
$134B
$1.41M 1.18%
3,890
– –
KMB icon
33
Kimberly-Clark
KMB
$37B
$1.4M 1.17%
10,500
– –
PAAS icon
34
Pan American Silver
PAAS
$18.6B
$1.39M 1.16%
107,769
-63
-0.1% -$760
BMY icon
35
Bristol-Myers Squibb
BMY
$128B
$1.31M 1.1%
28,975
-200
-0.7% -$9.32K
RTX icon
36
RTX Corp
RTX
$294B
$1.23M 1.03%
14,999
-158
-1% -$13.2K
VZ icon
37
Verizon
VZ
$198B
$1.23M 1.02%
21,492
-855
-4% -$49.3K
JNJ icon
38
Johnson & Johnson
JNJ
$641B
$1.18M 0.98%
8,450
-100
-1% -$13.8K
K
39
DELISTED
Kellanova
K
$1.18M 0.98%
23,403
-134
-0.6% -$7.12K
TTE icon
40
TotalEnergies
TTE
$187B
$1.17M 0.98%
20,950
– –
SNY icon
41
Sanofi
SNY
$105B
$1.16M 0.96%
26,709
-75
-0.3% -$3.19K
T icon
42
AT&T
T
$167B
$1.08M 0.9%
42,584
-754
-2% -$18.1K
ABBV icon
43
AbbVie
ABBV
$454B
$1.07M 0.89%
14,733
-210
-1% -$16.5K
WY icon
44
Weyerhaeuser
WY
$17.2B
$1.03M 0.86%
39,066
-480
-1% -$12.2K
PFE icon
45
Pfizer
PFE
$141B
$956K 0.8%
23,267
-422
-2% -$16.8K
DNP icon
46
DNP Select Income Fund
DNP
$4.15B
$886K 0.74%
74,976
– –
AEM icon
47
Agnico Eagle Mines
AEM
$73B
$871K 0.73%
17,000
– –
COP icon
48
ConocoPhillips
COP
$141B
$834K 0.7%
13,670
-200
-1% -$12.4K
ORCL icon
49
Oracle
ORCL
$345B
$809K 0.67%
14,200
-1,000
-7% -$54.1K
BG icon
50
Bunge Global
BG
$22.8B
$805K 0.67%
14,450
– –
1
2
3 4

Similar funds

CCM
Cribstone Capital Management Augusta, Maine $172M AUM 13.58% 1-Year Est. Return
AWM
Aevitas Wealth Management Wellesley Hills, Massachusetts $169M AUM 9.55% 1-Year Est. Return
S
Schroders London, United Kingdom $185M AUM 16.04% 1-Year Est. Return
BFS
Bickling Financial Services Lexington, Massachusetts $160M AUM 18.81% 1-Year Est. Return
SCM
Snowhook Capital Management New York $187M AUM 31.24% 1-Year Est. Return
RCC
Red Cedar Capital Omaha, Nebraska $158M AUM 6.57% 1-Year Est. Return
WWA
WC Walker & Associates Fullerton, California $189M AUM 16.91% 1-Year Est. Return
NEGWA
New England Guild Wealth Advisors Avon, Connecticut $190M AUM 17.1% 1-Year Est. Return

Bennicas & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Bennicas & Associates held 84 positions worth $120M, up 5.3% from $114M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 3.6%. Bennicas & Associates opened 2 new positions and exited 1, leaving the 84-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Materials.

  • Bennicas & Associates's largest Q2 2019 buy was Gabelli Healthcare & Wellness Trust: 137,500 shares worth $1.45M.
  • Bennicas & Associates added most to Newmont in Q2 2019, an estimated $1.09M increase.
  • Bennicas & Associates's biggest Q2 2019 reduction was Procter & Gamble, cutting an estimated $240K.
  • Bennicas & Associates fully exited Goldcorp Inc in Q2 2019, selling an estimated $1.16M.
  • Bennicas & Associates's ten largest holdings make up 40% of its $120M portfolio in Q2 2019.
  • Bennicas & Associates opened 2 new positions and closed 1 in Q2 2019.
  • Bennicas & Associates's portfolio value rose 5.3% quarter-over-quarter to $120M.

Based on Bennicas & Associates's 13F filing for Q2 2019, filed 12 Jul 2019.